share_log

Oppenheimer Maintains Outperform on Achieve Life Sciences, Lowers Price Target to $18

Benzinga ·  Dec 12, 2023 06:30

Oppenheimer analyst Francois Brisebois maintains Achieve Life Sciences (NASDAQ:ACHV) with a Outperform and lowers the price target from $21 to $18.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment